レボドパは,薬物誘発のエクストラピラミッド性疾患において,

Identifying immune signatures of sepsis to increase diagnostic accuracy in very preterm babies.

Nature communications·2024

Perinatal inflammation influences but does not arrest rapid immune development in preterm babies.

Nature communications·2020

Smoking in pregnancy is a key factor for sudden infant death among Māori.

Acta paediatrica (Oslo, Norway : 1992)·2018

Effectiveness of systemic treatments for pyoderma gangrenosum: a systematic review of observational studies and clinical trials.

The British journal of dermatology·2018

How important is the relationship between Protea humiflora (Proteaceae) and its non-flying mammal pollinators?

Oecologia·2017

The prevalence of anxiety in patients with psoriasis: a systematic review of observational studies and clinical trials.

Journal of the European Academy of Dermatology and Venereology : JEADV·2016

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Evaluation of brexpiprazole as adjunctive therapy in treatment-resistant depression: Real-world data.

Dusunen adam : Bakirkoy Ruh ve Sinir Hastaliklari Hastanesi yayin organi·2026

Unveiling the sumatriptan dose-relief relationship.

European journal of clinical pharmacology·2026

Comparison of Trough-Only and Peak-Trough Concentration Data for the Calculation of Vancomycin Area under the Concentration-Time Curve on Day 2 Using Previous and Updated Population Pharmacokinetic Models.

Biological & pharmaceutical bulletin·2026

Mapping Therapeutic Drug Monitoring Research in Low- and Middle-Income Countries: A Scoping Review (2015-2024).

Therapeutic drug monitoring·2026

Polymeric systems for peptide and protein delivery: design principles, translational barriers, and future research directions.

International journal of pharmaceutics·2026

Safety, tolerability, and efficacy of flexible-dose tavapadon for Parkinson's disease (TEMPO-2): a phase 3, randomised, placebo-controlled, double-blind trial.

The Lancet. Neurology·2026

関連する実験動画

レボドパは,薬物誘発のエクストラピラミッド性疾患において,

関連する概念動画

Identifying immune signatures of sepsis to increase diagnostic accuracy in very preterm babies.

Perinatal inflammation influences but does not arrest rapid immune development in preterm babies.

Smoking in pregnancy is a key factor for sudden infant death among Māori.

Effectiveness of systemic treatments for pyoderma gangrenosum: a systematic review of observational studies and clinical trials.

How important is the relationship between Protea humiflora (Proteaceae) and its non-flying mammal pollinators?

The prevalence of anxiety in patients with psoriasis: a systematic review of observational studies and clinical trials.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Evaluation of brexpiprazole as adjunctive therapy in treatment-resistant depression: Real-world data.

Unveiling the sumatriptan dose-relief relationship.

Comparison of Trough-Only and Peak-Trough Concentration Data for the Calculation of Vancomycin Area under the Concentration-Time Curve on Day 2 Using Previous and Updated Population Pharmacokinetic Models.

Mapping Therapeutic Drug Monitoring Research in Low- and Middle-Income Countries: A Scoping Review (2015-2024).

Polymeric systems for peptide and protein delivery: design principles, translational barriers, and future research directions.

Safety, tolerability, and efficacy of flexible-dose tavapadon for Parkinson's disease (TEMPO-2): a phase 3, randomised, placebo-controlled, double-blind trial.

関連する実験動画

レボドパは,薬物誘発のエクストラピラミッド性疾患において,

関連する概念動画

関連記事